Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Journal of Thrombosis and Thrombolysis
Published in: Journal of Thrombosis and Thrombolysis 2/2015

01-08-2015 | Erratum

Erratum to: Inferior vena cava filters: current best practices

Author: Anita Rajasekhar

Published in: Journal of Thrombosis and Thrombolysis | Issue 2/2015

Login to get access

Excerpt

In the original publication, a reference was mistakenly omitted by the author during manuscript preparation. The reference should be cited after the statement “Internationally, US providers place far more IVCFs compared to European providers by a staggering 25:1 IVCF placement ratio with no significant difference in annual VTE-related deaths [16–18]” on p. 316 of the April 2015 issue of The Journal of Thrombosis and Thrombolysis. …
Metadata
Title
Erratum to: Inferior vena cava filters: current best practices
Author
Anita Rajasekhar
Publication date
01-08-2015
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 2/2015
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-015-1240-4

Other articles of this Issue 2/2015

Journal of Thrombosis and Thrombolysis 2/2015 Go to the issue

OriginalPaper

Evaluation of medical costs avoided when new oral anticoagulants are used for extended treatment of venous thromboembolism based on clinical trial results

OriginalPaper

Sickle cell disease is associated with iron mediated hypercoagulability

ReviewPaper

Novel oral anticoagulants in patients undergoing cardioversion for atrial fibrillation

OriginalPaper

Analysis of anticoagulant prescribing in non-valvular atrial fibrillation and development of a clinical tool for guiding anticoagulant selection

OriginalPaper

Alcohol use disorders are associated with venous thromboembolism

OriginalPaper

A systematic review of contemporary trials of anticoagulants in orthopaedic thromboprophylaxis: suggestions for a radical reappraisal
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits